Pi Pharma Intelligence’s Contributions Extend Beyond the Pharmaceutical Industry to Include Academia

We are glad to see Pi Pharma Intelligence rising as a trusted provider of data, Today marks our first contribution to an article published at the Annals of Pharmacotherapy on Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma with BRAF Mutation, we thank all the authors for their trust and special thanks to our advisor Dr.Nimer Alkhatib